Entest Biomedical, Inc. subsidiary of Bio-Matrix Scientific Group, Inc. is seeking acquisitions. Entest Biomedical focuses on developing and commercializing therapies, medical devices, and medical testing procedures for the veterinary market, as well as on acquiring and operating veterinary clinics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2020 | Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019 | CI |
2019 | Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.92K | |
+158.06% | 6.17B | |
+0.47% | 998M | |
+2.10% | 982M | |
+41.91% | 872M | |
+22.89% | 803M | |
+1.63% | 663M | |
-1.80% | 596M | |
-.--% | 600M | |
+32.01% | 601M |
- Stock Market
- Equities
- ETNI Stock
- News Entest Group, Inc.
- Entest Biomedical Mulls Acquisitions